Mitochondria: Aspects for neuroprotection

Citation
Pe. Hart et Ahv. Schapira, Mitochondria: Aspects for neuroprotection, DRUG DEV R, 46(1), 1999, pp. 57-66
Citations number
95
Categorie Soggetti
Pharmacology & Toxicology
Journal title
DRUG DEVELOPMENT RESEARCH
ISSN journal
02724391 → ACNP
Volume
46
Issue
1
Year of publication
1999
Pages
57 - 66
Database
ISI
SICI code
0272-4391(199901)46:1<57:MAFN>2.0.ZU;2-3
Abstract
The understanding of mitochondrial biology and, subsquently, the role of mi tochondrial pathology in human disease has increased exponentially over the past 30 years. As insight has increased, so attention has begun to shift t o the possibilities for treating mitochondrially based disorders. There are a number of archetypal mitochondrial diseases, each associated with specif ic mitochondrial DNA mutations, deletions, or depletions. In addition there are a number of disorders, mainly neurodegenerative in nature, in which mi tochondrial dysfunction appears to play a pivotal role. Mitochondrial struc ture and function are discussed. Treatment of the archetypal mitochondrial disorders and other neurogenerative conditions is reviewed, with specific e mphasis on the prospects for neuroprotection. (C) 1998 Wiley-Liss, Inc.